Skip to main content
FOCIS 2025 Main banner
Final Program


Final Program
ViewAttendees 1

Immunoengineering and Therapeutics

Thursday, June 26, 2025
4:25pm - 6:25pm East Coast USA Time
Location: Salons F-G

Presentations:

  • 4:25pm - 4:40pm East Coast USA Time
    Engineering Thymic Selection to Promote Acceptance of Allogeneic Transplantation

    Presenting Author: Valentina Consoli – IRCCS Ospedale San Raffaele, San Raffaele Telethon Institute for Gene Therapy

  • 4:40pm - 4:55pm East Coast USA Time
    Induction of Antigen-Specific T Cell Tolerance by CNP-104 Positively Affects Clinical Response in Primary Biliary Cholangitis (PBC)

    Presenting Author: Adam Elhofy, PhD – COUR Pharmaceuticals

    Co-Author: Molly A. Frey, PhD – COUR Pharmaceuticals

  • 4:55pm - 5:10pm East Coast USA Time
    Combinatorial Genetic Engineering Strategy for Antigen-specific Protection of Stem Cell-derived Beta Cells by Chimeric Antigen Receptor Regulatory T Cells

    Presenting Author: Leonardo M.R. Ferreira, PhD – Medical University of South Carolina

  • 5:10pm - 5:25pm East Coast USA Time
    Engineering of Regulatory T Cells with Hepatocyte-specific Chimeric Antigen Receptor Enhances Liver Tissue Trafficking

    Presenting Author: Marc Martinez-Llordella, PhD – Quell Therapeutics

  • 5:25pm - 5:40pm East Coast USA Time
    Discovery and Characterization of a Novel Engineered Fc-fused IgE Cleaving Enzyme for Treatment of IgE Mediated Diseases

    Presenting Author: Nam Le – Seismic Therapeutic

  • 5:40pm - 5:55pm East Coast USA Time
    SBT115301, a Second Generation CD2-targeting LFA3 Fusion Protein to Restore Immune Homeostasis in Autoimmune Disease

    Presenting Author: Hervé Lebrec, PharmD, PhD, DABT – Sonoma Biotherapeutics

  • 5:55pm - 6:10pm East Coast USA Time
    Engineered Cellular Therapies Targeting 9G4 Idiotope B Cells in Autoimmune Diseases and Lymphoma

    Presenting Author: Jin Liu – Johns Hopkins University

  • 6:10pm - 6:25pm East Coast USA Time
    Chemokine-engineered CAR-T Cells for Autoimmunity: Multiplexed mRNA Technology for Improved Mode of Action and Safety

    Presenting Author: Norman M. Drzeniek, MD, PhD – Charité – University Medicine Berlin, BIH Center for Regenerative Therapies